# A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)

Source: https://onco.cc/trials/nct06118333/  
OnCo record `nct06118333` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Izalontamab brengitecan, Capecitabine, Gemcitabine in nasopharyngeal carcinoma, run by Sichuan Baili Pharmaceutical Co., Ltd., active and no longer recruiting.

## Summary

A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01) is a phase 3 interventional study registered as NCT06118333 by Sichuan Baili Pharmaceutical Co., Ltd., with 386 participants enrolled, started 2023-12-04 and due to reach its primary completion in 2026-11. Interventions recorded: BL-B01D1, capecitabine, gemcitabine, docetaxel. Conditions listed: Nasopharyngeal Carcinoma. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06118333
- Phase: 3
- Setting: A Phase III Randomized Controlled Trial to Compare BL-B01D1 With Physician's Choice of Chemotherapy (Last Line) in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Previously Treated With PD-1/PD-L1 Monoclonal Antibody and at Least Two Lines of Chemotherapy (at Least One Line of Platinum-based Chemotherapy)
- Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
- Enrolled: 386

## Sources

- ClinicalTrials.gov NCT06118333: https://clinicaltrials.gov/study/NCT06118333

## Connected records

- cancers: [Nasopharyngeal carcinoma](https://onco.cc/cancers/nasopharyngeal/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [Docetaxel](https://onco.cc/drugs/docetaxel/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Izalontamab brengitecan](https://onco.cc/drugs/izalontamab-brengitecan/)
- companies: [SystImmune / Sichuan Biokin](https://onco.cc/companies/systimmune/)

---
JSON: https://onco.cc/api/v1/entities/nct06118333.json